Clinical Stage Drug Discovery Based on Our Proprietary Platform Technology

SMNH: Delivering Novel Chemistry Solutions for Today's Diseases

SB 9200: A Potential Breakthrough Drug for HBV

Latest News

    • NOVEMBER 15, 2011

    Spring Bank Pharmaceuticals Receives Allowance for US Patent

    Spring Bank Pharmaceuticals Receives Allowance for US Patent entitled Nucleotide and Oligonucleotide Prodrugs Milford, MA, November 15, 2011 – Spring Bank Pharmaceuticals, Inc., announces that the United States Patent and Trademark Office has allowed the U.S. patent 11/637,520 (“the patent”) titled “Nucleotide and Oligonucleotide Prodrugs”, co-inventors Iyer and Padmanabhan. This patent relates to the design,

    Read more